Press Release

Article

Fox Chase Cancer Center’s Biosample Repository Receives Reaccreditation From College of American Pathologists

Key Takeaways

  • Fox Chase Cancer Center’s Biosample Repository Facility achieved CAP reaccreditation, highlighting its commitment to high standards in biospecimen management and research integrity.
  • CAP accreditation is recognized for rigorous standards, enhancing quality and reducing risk, contributing to improved patient outcomes.
SHOW MORE

Fox Chase Cancer Center’s Biosample Repository Facility was recently awarded reaccreditation by the College of American Pathologists based on the results of an on-site inspection.

Jonathan Chernoff, MD, PhD

Jonathan Chernoff, MD, PhD

Fox Chase Cancer Center’s Biosample Repository Facility was recently awarded reaccreditation by the College of American Pathologists (CAP) based on the results of an on-site inspection.

A biorepository is used for the collection, processing, storage, dissemination, and analysis of biological samples and associated clinical data for research purposes. Repositories like the one at Fox Chase fill an essential role by facilitating translational research associated with clinical trials and basic research.

“The reaccreditation of the Biosample Repository Facility is a significant milestone, demonstrating our commitment to the highest standards in biospecimen management and research integrity,” said Johanna James, the facility’s manager.

“This achievement is a testament to the dedication and resilience of our staff, whose expertise and unwavering commitment ensure the highest quality, compliance, and reliability in our operations. This recognition further strengthens our role in supporting groundbreaking scientific research and innovation,” she added.

“This reaccreditation demonstrates to our patients that our facilities meet the highest quality standards,” said Jonathan Chernoff, MD, PhD, Cancer Center Director. “We are proud that our Biosample Repository Facility has been reaccredited by CAP, and we look forward to seeing how our facility will continue to serve as a vital tool in conducting groundbreaking research for the community.”

Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient outcomes. Fox Chase’s repository is one of more than 8,000 CAP-accredited facilities worldwide.

During the CAP accreditation process, which is designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management. These reviews help verify activities and reflect the most recent best practices.

With over 23,000 laboratory participants, in addition to accreditation, CAP offers proficiency testing/external quality assessment programs, quality improvement tools, and protocols and guidelines to ensure excellence in all areas across the laboratory. Built on a foundation of pathologist expertise, CAP partners with laboratories worldwide to elevate the quality of laboratory medicine with best-in-class solutions designed to drive operational excellence, achieve diagnostic confidence, and ensure the best patient care.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Addressing Unmet Needs in HER2+ Metastatic BTC
Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 24th 2025 - Apr 25th 2026

online-activity
Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2
Video

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

Apr 23rd 2025 - Apr 24th 2026

online-activity
(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments
Video

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Apr 23rd 2025 - Apr 24th 2026

online-activity